Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy

Investigative Radiology

Volumn 33, Issue 8, 1998, Pages 450-455

  Choe, Bo Young ^a,b   Park, Jeong Wook ^a   Lee, Kwang Soo ^a   Son, Byung Chul ^a   Kim, Moon Chan ^a   Kim, Bum Soo ^a   Suh, Tae Suk ^a   Lee, Hyoung Koo ^a   Shinn, Kyung Sub ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

1H magnetic resonance; Parkinson's disease; Spectroscopy

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN; SUBSTANTIA NIGRA; SYMPTOMATOLOGY;

EID: 0032471783     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199808000-00005     Document Type: Article

References (22)

1. Daniel SE. The neuropathology and neurochemistry of multiple system atrophy. In: Bannister R, Mathias C, eds. Autonomie failure. 3rd ed. Oxford: Oxford University Press, 1992.
2. Federico F, Simone IL, Lucivero V, et al. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1997;62:239-242.
3. Gouider-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y. "pure" striatonigral degeneration and Parkinson's disease: A comparative clinical study. Mov Disord 1995;10:288-294.
4. Quinn N. Multiple system atrophy: The nature of the beast. J Neurol Neurosurg Psychiatry 1989;57(suppl):78-79.
5. Bottomley PA. Human in vivo NMR spectroscopy in diagnostic medicine: Clinical tool or research probe? Radiology 1989;170:1-15.
6. Lenkinski RE. Clinical MR spectroscopy. In: Kressel HY, Modic MT, Murphy WA, eds. Syllabus, special course: MR 1990. Chicago, IL: Radiological Society of North America, 1990.
7. Hushes A, Daniel S, Kilford L, Lees A. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
8. Frahm J, Merbold KD, Hanicke W. Localized proton spectroscopy using stimulated echoes. J Magn Reson 1987;72:502-508.
9. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93.
10. 1H NMR spectroscopy in patients with chronic hepatic encephalopathy: Analysis of change in cerebral glutamine, choline, and inositols. NMR in Biomed 1991;4:109-116.
11. Petroff OAC, Spencer DD, Alger JR, Prichard JW. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989;39:1197-1202.
12. Ross B, Kreis R, Ernst T. Clinical tools for the 90s: Magnetic resonance spectroscopy and metabolic imaging. Eur J Radiology 1992;14:128-140.
13. Drayer BP, Olanow W, Burger P, et al. Parkinson plus syndrome: Diagnosis using high held MR imaging of brain iron. Radiology 1989;159:493-498.
14. Stern MB, Braffman BH, Skolnick BE, et al. Magnetic resonance imaging in Parkinson's disease and Parkinsonian syndromes. Neurology 1989;39:1524-1526.
15. Holshouser BA, Komu M, Moller HE, et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: A multicenter pilot study. Magn Reson Med 1995;33:589-594.
16. Federico F, Simone IL, Lucivero V, et al. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1997;62:239-242.
17. Clarke CE, Lowry M, Horsman A. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy. Mov Disord 1997;12:297-301.
18. Davie CA, Wenning GK, Barker GJ, et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 1995;37:204-210.
19. Bowen BC, Block RE, Sanchez-Ramos J, et al. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR Am J Neuroradiiol 1995;16:61-68.
20. Nadler JV, Cooper JR. N-acetyl-L-aspartatic acid content of human neural tumors and bovine peripheral nervous tissues. J Neurochem 1972;19:313-319.
21. 1H NMR spectroscopy: N-acetylaspartate, creatine and choline. NMR Biomed 1991;4:47-52.
22. Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness? Ann Neurol 1992;31: 119-130.